Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated May 15, 2023. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q1 2023. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 21.2B USD
- Positions
- 80
- Share of the ten largest
- 43.1%
The ten largest positions Q1 2023
- Visa Inc. 7.0%▲ +13.4%
- McKesson Corporation 5.4%▲ +45.5%
- UnitedHealth Group 4.7%▲ +65.7%
- Elevance Health 4.7%▲ +15.1%
- GE Aerospace 3.9%▲ +10.8%
- Fortinet 3.7%▲ +66.6%
- Amazon 3.7%▼ −38.9%
- Api Group Corp 3.6%▲ +0.8%
- Lululemon Athletica 3.2%new
- Meta Platforms 3.2%▲ +35.3%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q1 2023
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| AMZN Amazon | 3.7% | 7,628,220 | 787.9M USD | −38.9% reduced | Q2 2015 32 quarters |
| MSFT Microsoft | 1.4% | 1,047,352 | 302.0M USD | −69.5% reduced | Q2 2016 28 quarters |
| V Visa Inc. | 7.0% | 6,560,069 | 1.5B USD | +13.4% increased | Q3 2016 27 quarters |
| Catalent Inc | 0.4% | 1,201,210 | 78.9M USD | −15.7% reduced | Q1 2018 21 quarters |
| BSX Boston Scientific | 0.3% | 1,136,881 | 56.9M USD | −88.1% reduced | Q3 2018 19 quarters |
| Bridgebio Pharma Inc | 2.1% | 26,620,991 | 441.4M USD | unchanged | Q2 2019 16 quarters |
| Adaptive Biotechnologies Cor | 1.2% | 29,993,708 | 264.8M USD | unchanged | Q2 2019 16 quarters |
| FTV Fortive | 2.0% | 6,346,528 | 432.6M USD | +63.1% increased | Q3 2019 15 quarters |
| Molina Healthcare Inc | 0.7% | 594,553 | 159.0M USD | +1.1% increased | Q3 2019 15 quarters |
| Guardant Health Inc | 0.3% | 2,538,889 | 59.5M USD | −38.2% reduced | Q3 2019 15 quarters |
| CB Chubb Limited | 3.2% | 3,466,740 | 673.2M USD | −3.2% reduced | Q1 2020 13 quarters |
| Api Group Corp | 3.6% | 34,090,285 | 766.3M USD | +0.8% increased | Q2 2020 12 quarters |
| TMO Thermo Fisher Scientific | 2.3% | 856,836 | 493.9M USD | +2.1% increased | Q2 2020 12 quarters |
| Royalty Pharma PLC | 1.9% | 11,204,249 | 403.7M USD | +11.9% increased | Q2 2020 12 quarters |
| Karuna Therapeutics Inc | 1.3% | 1,501,074 | 272.7M USD | +26.8% increased | Q3 2020 11 quarters |
| Inhibrx Inc | 0.6% | 6,639,199 | 125.3M USD | unchanged | Q3 2020 11 quarters |
| GE GE Aerospace | 3.9% | 8,612,232 | 823.3M USD | +10.8% increased | Q4 2020 10 quarters |
| META Meta Platforms | 3.2% | 3,229,914 | 684.5M USD | +35.3% increased | Q4 2020 10 quarters |
| Acadia Healthcare Company In | 1.1% | 3,354,110 | 242.3M USD | +6.1% increased | Q4 2020 10 quarters |
| 4D Molecular Therapeutics In | 0.3% | 3,937,914 | 67.7M USD | unchanged | Q4 2020 10 quarters |
| Kinnate Biopharma Inc | < 0.1% | 1,820,462 | 11.4M USD | unchanged | Q4 2020 10 quarters |
| AMP Ameriprise Financial | 1.4% | 941,040 | 288.4M USD | −42.9% reduced | Q1 2021 9 quarters |
| CRL Charles River Laboratories | 0.4% | 394,089 | 79.5M USD | −23.5% reduced | Q1 2021 9 quarters |
| Zai Lab Ltd | 0.4% | 2,331,245 | 77.5M USD | +18.1% increased | Q1 2021 9 quarters |
| Edgewise Therapeutics Inc | 0.2% | 4,909,146 | 32.7M USD | +11.3% increased | Q1 2021 9 quarters |
| Pharvaris N V | 0.1% | 3,231,923 | 25.3M USD | unchanged | Q1 2021 9 quarters |
| Intellia Therapeutics Inc | 0.3% | 1,569,545 | 58.5M USD | −22.4% reduced | Q2 2021 8 quarters |
| Day One Biopharmaceuticals I | < 0.1% | 1,558,563 | 20.8M USD | unchanged | Q2 2021 8 quarters |
| Talaris Therapeutics Inc | < 0.1% | 3,289,617 | 6.2M USD | unchanged | Q2 2021 8 quarters |
| Hdfc Bank Ltd | 2.6% | 8,285,627 | 552.4M USD | −3.3% reduced | Q3 2021 7 quarters |
| Ginkgo Bioworks Holdings Inc | 0.9% | 143,085,126 | 190.3M USD | +126.8% increased | Q3 2021 7 quarters |
| Rallybio Corp | 0.1% | 4,194,777 | 24.0M USD | unchanged | Q3 2021 7 quarters |
| Roivant Sciences Ltd | 3.1% | 88,238,700 | 651.2M USD | unchanged | Q4 2021 6 quarters |
| Biomarin Pharmaceutical Inc | 1.0% | 2,168,617 | 210.9M USD | −58.9% reduced | Q4 2021 6 quarters |
| XYZ Block, Inc. | 0.8% | 2,354,123 | 161.6M USD | −47.5% reduced | Q4 2021 6 quarters |
| IFF International Flavors & Fragrances | 0.4% | 812,680 | 74.7M USD | +85.0% increased | Q4 2021 6 quarters |
| Lianbio | < 0.1% | 3,564,173 | 7.0M USD | unchanged | Q4 2021 6 quarters |
| ELV Elevance Health | 4.7% | 2,154,556 | 990.7M USD | +15.1% increased | Q1 2022 5 quarters |
| MA Mastercard | 1.4% | 796,740 | 289.5M USD | −53.4% reduced | Q1 2022 5 quarters |
| Unum Group | 0.8% | 4,253,413 | 168.3M USD | +24.0% increased | Q1 2022 5 quarters |
| PGR Progressive Corporation | 0.7% | 1,003,562 | 143.6M USD | +197.9% increased | Q1 2022 5 quarters |
| Amylyx Pharmaceuticals Inc | 0.4% | 2,962,555 | 86.9M USD | −36.1% reduced | Q1 2022 5 quarters |
| Inspire Med Sys Inc | 0.4% | 346,576 | 81.1M USD | −37.0% reduced | Q1 2022 5 quarters |
| MCK McKesson Corporation | 5.4% | 3,207,080 | 1.1B USD | +45.5% increased | Q2 2022 4 quarters |
| INTU Intuit | 2.6% | 1,221,094 | 544.4M USD | +3.3% increased | Q2 2022 4 quarters |
| MU Micron Technology | 0.8% | 2,856,599 | 172.4M USD | −65.8% reduced | Q2 2022 4 quarters |
| Pepgen Inc | < 0.1% | 1,544,631 | 18.9M USD | unchanged | Q2 2022 4 quarters |
| Verastem Inc | < 0.1% | 9,224,000 | 3.8M USD | unchanged | Q2 2022 4 quarters |
| UNH UnitedHealth Group | 4.7% | 2,099,991 | 992.4M USD | +65.7% increased | Q3 2022 3 quarters |
| Valvoline Inc | 1.2% | 7,398,713 | 258.5M USD | +51.7% increased | Q3 2022 3 quarters |
| Rogers Comms B | 1.2% | 5,554,500 | 257.4M USD | +27.0% increased | Q3 2022 3 quarters |
| CDNS Cadence Design Systems | 1.2% | 1,225,306 | 257.4M USD | +8.0% increased | Q3 2022 3 quarters |
| Trevi Therapeutics Inc | < 0.1% | 4,400,000 | 8.1M USD | unchanged | Q3 2022 3 quarters |
| FTNT Fortinet | 3.7% | 11,875,384 | 789.2M USD | +66.6% increased | Q4 2022 2 quarters |
| CSX CSX Corporation | 3.1% | 22,057,119 | 660.4M USD | +41.9% increased | Q4 2022 2 quarters |
| Seagate Technology Hldngs Pl | 1.7% | 5,513,957 | 364.6M USD | −11.0% reduced | Q4 2022 2 quarters |
| Equitable HLDGS Inc | 0.5% | 3,989,446 | 101.3M USD | −23.5% reduced | Q4 2022 2 quarters |
| Kbr Inc | 0.4% | 1,679,474 | 92.5M USD | +55.9% increased | Q4 2022 2 quarters |
| Newamsterdam Pharma Company | 0.2% | 3,915,870 | 52.6M USD | +4.3% increased | Q4 2022 2 quarters |
| Farfetch Ltd | 0.2% | 7,103,457 | 34.9M USD | +4.9% increased | Q4 2022 2 quarters |
| LULU Lululemon Athletica | 3.2% | 1,893,883 | 689.7M USD | new | Q1 2023 1 quarter |
| SHW Sherwin-Williams | 2.4% | 2,252,060 | 506.2M USD | new | Q1 2023 1 quarter |
| EMR Emerson Electric | 1.0% | 2,400,879 | 209.2M USD | new | Q1 2023 1 quarter |
| Zoominfo Technologies Inc | 0.8% | 6,666,576 | 164.7M USD | new | Q1 2023 1 quarter |
| CEG Constellation Energy | 0.8% | 2,047,688 | 160.7M USD | new | Q1 2023 1 quarter |
| WDAY Workday, Inc. | 0.6% | 642,447 | 132.7M USD | new | Q1 2023 1 quarter |
| Coupang Inc | 0.6% | 7,421,453 | 118.7M USD | new | Q1 2023 1 quarter |
| RIVN Rivian Automotive | 0.4% | 5,250,417 | 81.3M USD | new | Q1 2023 1 quarter |
| SNPS Synopsys | 0.4% | 205,032 | 79.2M USD | new | Q1 2023 1 quarter |
| Alkermes PLC | 0.4% | 2,781,917 | 78.4M USD | new | Q1 2023 1 quarter |
| TRV Travelers Companies (The) | 0.3% | 378,345 | 64.9M USD | new | Q1 2023 1 quarter |
| SNOW Snowflake | 0.3% | 382,757 | 59.1M USD | new | Q1 2023 1 quarter |
| CL Colgate-Palmolive | 0.2% | 660,698 | 49.7M USD | new | Q1 2023 1 quarter |
| DELL Dell Technologies | 0.2% | 1,094,394 | 44.0M USD | new | Q1 2023 1 quarter |
| Cnh Indl N V | 0.2% | 2,827,515 | 43.2M USD | new | Q1 2023 1 quarter |
| MRSH Marsh McLennan | 0.2% | 257,443 | 42.9M USD | new | Q1 2023 1 quarter |
| Option Care Health Inc | 0.2% | 1,090,497 | 34.6M USD | new | Q1 2023 1 quarter |
| Viking Therapeutics Inc | 0.2% | 1,955,063 | 32.6M USD | new | Q1 2023 1 quarter |
| TJX TJX Companies | 0.2% | 414,401 | 32.5M USD | new | Q1 2023 1 quarter |
| First Rep Bk San Francisco C | < 0.1% | 276,260 | 3.9M USD | new | Q1 2023 1 quarter |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Plus 1 position in convertible bonds and bonds worth 81.0M USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Guardant Health Inc principal 120.0M USD 81.0M USD
Breakdown by sector
- Health Care 17.7%
- Financials 14.8%
- Technology 11.2%
- Industrials 10.0%
- Consumer Discretionary 7.5%
- Communication Services 3.2%
- Materials 2.7%
- Utilities 0.8%
- Consumer Staples 0.2%
- not in our coverage 31.8%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors